自由呼吸呼气门控10MV FFF VMAT肺立体定向放疗的临床经验
本研究纳入2019年9月至2023年2月接受呼气门控肺SBRT的41例患者(50个靶区),采用10MV FFF VMAT技术,评估治疗时间、肿瘤稳定性及临床结局。呼气门控SBRT使纵向肿瘤运动和ITV分别减少77%和42%,同侧肺V5/V20Gy平均降低21%/24%,中位随访13个月未见局部复发。作者认为该技术可行、有效且实用。
要点
- 呼气门控SBRT使纵向肿瘤运动减少77%、ITV减少42%。
- 同侧肺V5/V20Gy平均分别降低21%和24%。
- 86%的分次治疗在25分钟内完成,中位随访13个月无局部复发。
核心结论
- 自由呼吸呼气门控SBRT是肺癌治疗中可行、有效且实用的方法,能显著减少肿瘤运动和肺剂量,同时保持高治疗精度和可接受的治疗时间。
研究设计与样本
- 研究纳入2019年9月至2023年2月接受呼气门控肺SBRT的41例患者共50个靶区。
- 患者接受自由呼吸无指导10相4DCT用于计划,呼气门控选择基于肿瘤运动、危及器官剂量、自由呼吸CBCT上预期靶区可见性及呼吸模式适宜性。
- 门控窗通常设为呼吸周期的30%~70%相,治疗计划采用10MV FFF VMAT,肿瘤运动通过呼气门控CBCT±近实时无标记kV成像监测。
- 对10例患者子集比较呼气门控与自由呼吸计划的剂量学结果。
主要发现
- 呼气门控SBRT使纵向肿瘤运动和ITV分别减少77%和42%。
- 同侧肺V5/V20Gy平均分别降低21%和24%。
- 20个靶区的治疗中运动监测显示大多数患者分次内肿瘤运动保持在2mm以内。
- 86%的分次治疗在25分钟内完成。
- 中位随访13个月期间未观察到局部复发。
临床怎么用
- 作者认为自由呼吸呼气门控SBRT是肺癌治疗中可行、有效且实用的方法。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Free-breathing expiration-gating (EG) is a non-invasive technique used to manage respiratory-induced tumor motion. This study explores the effectiveness of EG stereotactic body radiotherapy (SBRT) for lung tumors using 10MV FFF VMAT. METHODS AND MATERIALS: The study included 41 patients (50 targets) treated with EG lung SBRT between September 2019 and February 2023. Patients underwent free-breathing uncoached 10-phase 4DCT for planning, with the choice for EG based on e.g. tumor motion, critical organ dose, expected target visibility on free-breathing CBCT, taking into account suitability of the breathing pattern. The gating window was typically set at phases 30-70 % of the breathing cycle. Treatment planning utilized VMAT with 10MV FFF, and tumor motion was monitored using EG-CBCT ± near real-time markerless kV imaging. Treatment times for the different parts of treatment, tumor stability and clinical outcomes were evaluated. Dosimetric outcomes were compared between EG and free-breathing plans for a subset of 10 patients. RESULTS: EG SBRT substantially reduced longitudinal tumor motion and internal target volume (ITV) by 77 % and 42 % respectively. There was a mean decrease of 21/24 % in V5/V20Gy for the ipsilateral lung. Motion monitoring during treatment for 20 targets showed that intrafraction tumor motion remained within 2 mm for most patients, ensuring accurate dose delivery. 86 % of fractions were completed within 25 min. No local recurrences were observed during a median follow-up of 13 months. CONCLUSION: Free-breathing EG SBRT is a feasible, effective, and practical approach for lung cancer treatment, offering significant reductions in tumor motion and lung doses while maintaining high treatment accuracy and acceptable treatment times.
引用
- Remmerts de Vries IF, Dahele M, Rosario TS, et al. Clinical experience with free-breathing expiration-gated 10MV FFF VMAT stereotactic lung radiotherapy. Radiother Oncol. 2025. PMID: 39952436. doi:10.1016/j.radonc.2025.110783
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。